{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:29:09Z","timestamp":1768339749934,"version":"3.49.0"},"reference-count":15,"publisher":"Wiley","issue":"S60","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4527,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1996,12]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Drug\u2010related blood dyscrasias as reported in Sweden during a 10\u2010yr period have been analysed in relation to sales and prescription data. The number of cases reported were as follows: agranulocytosis 390, thrombocytopenia 391, pancytopenia 50 and aplastic anaemia 36. The annual incidence rates per 10<jats:sup>6<\/jats:sup> inhabitants were: agranulocytosis 4.8, thrombocytopenia 5.6, pancytopenia 1.1 and aplastic anaemia 0.5. Incidences in the elderly were higher for all dyscrasias except aplastic anaemia. The most commonly reported drugs for all dyscrasias were sulphonamides and diuretics, but when related to sales data the risk of agranulocytosis was high for clozapine, dapsone, mianserin and sulphasalazine, while the risk did not seem to be increased for furosemide. For thrombocytopenia, furosemide, co\u2010trimoxazole and the measles, mumps and rubella vaccine were most commonly reported. The risk for pancytopenia and aplastic anaemia was increased for acetazolamide and co\u2010trimoxazole. As spontaneous reporting systems are primarily set up for signalling purposes, such data must always be interpreted with utmost care.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1996.tb01644.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T08:46:23Z","timestamp":1279442783000},"page":"42-46","source":"Crossref","is-referenced-by-count":37,"title":["Drug\u2010related blood dyscrasias in a Swedish reporting system, 1985\u20131994"],"prefix":"10.1111","volume":"57","author":[{"given":"Bengt\u2010Erik","family":"Wiholm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Staffan","family":"Emanuelsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.286.6361.289"},{"key":"e_1_2_1_3_2","unstructured":"WiholmB\u2010E LindquistM.The detection and evaluation of drug\u2010induced agranulocytosis by spontaneous reports. Clinical Pharmacology and Therapeutics Conference Stockholm Sweden1986 Abstr 1061."},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91669-2"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5875.339"},{"key":"e_1_2_1_6_2","volume-title":"The drug etiology of agranulocytosis and aplastic anemia","author":"Kaufman DW","year":"1991"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1990.tb00245.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1990.tb00290.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archderm.1990.01670310081011","article-title":"The incidence of agranulocytosis during treatment of dermatitis herpetiformis as reported in Sweden 1972 through 1988","volume":"26","author":"H\u00f6rnsten P","year":"1990","journal-title":"Arch Dermatol"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02333012"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02333011"},{"key":"e_1_2_1_12_2","first-page":"26","volume":"498","author":"Westerholm B","year":"1972","journal-title":"WHO Technical Report Series"},{"key":"e_1_2_1_13_2","unstructured":"Nordic Statistics on Medicines1975\u20131977 Part II. Nordic Council on Medicines Box 26 S\u2010751 03 Uppsala Sweden."},{"key":"e_1_2_1_14_2","unstructured":"Swedish Drug Statistics. Apoteksbolaget S\u2010105 14 Stockholm."},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1981.tb09853.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1990.tb00407.x"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1996.tb01644.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1996.tb01644.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T11:17:05Z","timestamp":1698405425000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1996.tb01644.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":15,"journal-issue":{"issue":"S60","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["10.1111\/j.1600-0609.1996.tb01644.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1996.tb01644.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,12]]}}}